A B S T R A C T Circulating levels of immunoreactive
A B S T R A C T Circulating levels of immunoreactive parathyroid hormone (PTH) were measured in 40 patients with idiopathic hypercalciuria (IH) before and during reversal of hypercalciuria with thiazide, and in four normal subjects before and during induction of hypercalciuria with furosemide. 26 patients with IH had elevated serum PTH levels. The remaining patients had normal levels. Although the correlation was not complete, high PTH levels were generally found in patients who had more severe average urinary calcium losses. When initially elevated, PTH levels fell to normal or nearly normal values during periods of thiazide administration lasting up to 22 months. When initially normal, PTH levels were not altered by thiazide. Reversal of hyperparathyroidism by thiazide could not be ascribed to the induction of hypercalcemia, since serum calcium concentration failed to rise in a majority of patients. Renal hypercalciuria produced by furosemide administration elevated serum PTH to levels equivalent to those observed in patients with IH.
The findings in this study help to distinguish between several current alternative views of IH and its relationship to hyperparathyroidism. Alimentary ' is a syndrome characterized by normocalcemia and hypercalciuria that is unexplained by an established cause such as sarcoidosis, renal tubular acidosis, excessive intake of vitamin D or calcium, malignancy, immobilization, or rapidly progressive osteoporosis (1) . Kidney stones are very common, and there is a tendency towards hypophosphatemia. The syndrome occurs in approximately 3% of normal persons and in 30-40% of patients with nephrolithiasis (2) (3) (4) .
The mechanism of hypercalciuria has not been established. At present, three theories deserve special consideration. (a) Gastrointestinal calcium absorption is generally elevated in IH (5, 6) , and in certain patients hyperabsorption appears to be the predominent mechanism of hypercalciuria (7) . (b) Idiopathic hypercalciuria resembles primary hyperparathyroidism except that, by definition, hypercalcemia is absent. Because of this resemblance and the known variability of serum calcium levels in hyperparathyroidism, it has long been suspected that many patients who appear to have IH have instead a normocalcemic variety of primary hyperparathyroidism (8, 9) . (c) Excessive renal calcium loss can occur by virtue of defective tubular calcium real)sorption in interstitial and medullary renal diseases (10) . The notion that IH is due to defective renal tubular calcium reabsorption has not been critically tested. In an important experiment by Finn, a kidney from a father with IH was transplanted to the son (11) . The son did not develop hypercalciuria after transplantation, suggesting that the primary defect was extrarenal. However, this single observation does not exclude the possibility that, in many patients, hypercalciuria is of renal origin.
We have approached the problem of the pathogenesis of IH by studying parathyroid function using a sensitive radioimmunoassay for parathyroid hormone (PTH) (12) . If 
Normal subjects
Normal values were derived from normal subjects who were not under medical care and had no known illnesses. Four normal, healthy young men served as experimental subjects for the study of the effect upon serum PTH levels of hypercalciuria due to the administration of furosemide. In each case, a thorough medical history was obtained and a physical examination was performed by one of us.
Experimental design
Studies of IH. All patients were studied as outpatients. Initial evaluation of each patient was based upon four 24 h urine collections and four corresponding blood samples. Serum calcium, phosphorus, and creatinine levels and 24 h creatinine clearance were measured three times. Urinary calcium excretion was measured twice. Serum PTH was measured once. After this initial evaluation, patients were treated with trichlormethiazide (naqua), 2 mg orally, given twice daily. Subsequent measurements of urine calcium excretion, serum calcium, PTH, phosphorus and creatinine, and 24 h creatinine clearance were made at 3 or 4 month intervals.
Furosemide-induced hypercalciuria. 24 h urine calcium excretion, serum calcium, PTH, creatinine, and phosphorus levels, and 24 h creatinine clearance were measured on 3 consecutive days. Each subj ect then received furosemide, 40 mg orally, given twice daily, and supplemental sodium chloride, 50 mEq orally, given three times daily, for 9 consecutive days. All measurements were then repeated during the 7th, 8th, and 9th days of treatment.
Techniques of sample collection
Urines for calcium were collected in polypropyline bottles containing 10 ml of concentrated hydrochloric acid. Subjects were instructed in appropriate techniques of urine collection. Actual times of initiation and completion of each sample were recorded by the patient. All values were then computed to 24 h. Blood samples were drawn between 7:30 and 9:30 a.m. at the conclusion of each urine collection, while patients were in the postabsorptive state. A tourniquet for blood drawing was left in place no longer than 30 s; blood samples were not drawn until 2 min after release of the tourniquet. Blood and urine samples for calcium were diluted within 30 min of collection using automatic diluters in which samples contact parts made only of Tygon (Hobbs Corp., Miami, Fla.).
Laboratory methods
Calcium concentration was determined in serum and urine using atomic absorption spectrophotometry. All dilutions were made in a lithium-strontium diluent. Samples were each diluted three times, and each dilution was analyzed separately. If the three dilutions did not agree within 0.1 mg/100 ml, continued dilutions were made until three consecutive dilutions agreed within this limit. Ionized calcium concentration was measured using a flow-through liquid membrane electrode (Orion, series 98; Orion Research, Inc., Cambridge, Mass.). Circulating immunoreactive PTH was measured by a radioimmunoassay described in detail elsewhere (12) . Serum (Fig. 1 ). In the remaining 14 patients, hypercalciuria was present on one occasion but absent on the other (intermittent hypercalciuria) (Fig. 2) . Serum PTH values are shown for each patient along with an identifying patient number, drawn from the general stone program, and used later in this report for identifying patients during the course of treatment.
Serum PTH was higher among persistent than among intermittent hypercalciuric patients (Fig. 3 of particular interest, since PTH levels did not fall during sustained thiazide treatment.
Furosemide-induced hypercalciuria. Urinary calcium excretion increased in all four normal subjects given furosemide (Fig. 6) . Serum PTH rose in every subject, generally attaining levels comparable to those observed in patients with persistent IH. Total and ionized serum calcium remained constant. Serum phosphorus and 24 h creatinine clearance (not shown) also remained constant during furosemide administration.
DISCUSSION
Occurrence of hyperparathyroidism in IH. The interpretation of these data depends on the validity of the PTH assay. PTH is secreted into the circulation as the native 84 amino acid peptide (15) . Metabolism of the hormone generates one or more immunoreactive peptide fragments (15, 16) . Antisera to PTH contain antibodies that possess varying affinities for the intact hormone and its fragments. Since antisera vary widely in their specificity for hormone and fragment recognition, divergent results reported from various laboratories are not unexpected (17) . A recent preliminary report has suggested that the majority of immunoreactive PTH in the peripheral circulation is biologically inert, but the biologic activity of PTH fragments requires further study (18) .
The assay used in this study is characterized by excellent discrimination between normal and abnormal sera and by high sensitivity of PTH responses to physiologic stimuli (12, 19) . A critical evaluation of the usefulness and limitations of this assay has been presented elsewhere (14) . Approximately 20% of immunoreactive circulating PTH is the complete PTH molecule; the remainder represents fragments (16) . Whatever the biologic significance of the immunoreactive fragments is, there is little doubt that these assay results reflect long-term secretory activity of the parathyroid glands.
In keeping with our preliminary results, approximately two-thirds of subjects with IH have some degree Hyperparathyroidism in Idiopathic Hypercalciuria FIGuRE 6 Effects of furosemide-induced hypercalciuria upon serum PTH and total and ionized calcium concentrations in normal subjects. Urinary calcium excretion is shown for each subject as the mean +1 SE for 3 consecutive control days and days 7, 8, and 9 of furosemide administration. Serum PTH values are single determinations for each patient. Serum calcium concentrations are shown as means ±1 SE for all four subjects during control and experimental periods. B. W., body weight.
to assume that excessive renal calcium loss in some manner provoked hyperparathyroidism. This makes plausible the notion that serum PTH levels are elevated in IH by hypercalciuria itself.
The notion that hyperparathyroidism may be secondary to hypercalciuria is also supported by the fact that PTH levels were lowered appreciably by calcium infusion. Such suppression is characteristic of hyperplasia, the usual anatomical basis for secondary hyperparathyroidism, but not of parathyroid adenomas (14) .
Implication for the mechanism of hypercalciuria. Whether or not alimentary hyperabsorption is a mechanism of hypercalciuria in patients who have normal PTH levels cannot be decided on the basis of our current data; however, it is unlikely that IH results mainly from alimentary hyperabsorption of calcium in those patients who have hyperparathyroidism. Hyperabsorption could lead to normal or suppressed but not high serum PTH levels. In the well-studied example of sarcoidosis, where alimentary hyperabsorption is generally considered to be the major cause of hypercalciuria, serum PTH levels, measured by this immunoassay, were very low (13) . The finding of high serum PTH levels in two-thirds of patients with IH may explain why alimentary hyperabsorption of calcium has been found in many patients with this syndrome (5, 7) . Parathyroid hormone has a weak but distinct action to increase alimentary calcium absorption (23) . Possibly the high serum PTH levels in IH increase gastrointestinal calcium absorption. Overall, alimentary hyperabsorption could be the cause of III in those patients with normal PTH levels, but could not explain the occurrence of IH with hyperparathyroidism.
The fact that hyperparathyroidism found in IH reverses when hypercalciuria is suppressed with thiazide makes it highly unlikely that a normocalcemic form of primary hyperparathyroidism is the basis of this disorder. In addition, hyperparathyroidism was clearly absent in one-third of patients with IH. Primary hyperparathyroidism, as this disease is usually conceived, is therefore not an attractive mechanism for either form of IH. However, the slightly increased serum calcium in patients with the high PTH form of IH indicates that the normal relations between serum calcium and PTH were disrupted in this subgroup (21, 24) . This abnormality resembles primary chief cell hyperplasia, but in IH the apparently disturbed failure of feedback control operates at a much lower serum calcium concentration (14) . To the extent that this may be named a new form of primary hyperparathyroidism, the issue becomes one of semantics.
The remaining mechanism, a defect of renal tubular calcium reabsorption, provides a unitary explanation of IH, because it could be the basis for hypercalciuria both in patients with elevated and with normal PTH levels.
Primary renal hypercalciuria from furosemide elevated PTH levels in normal people. Patients with IH and high PTH levels could be analogous to these treated subjects. Normal PTH levels in IH do not exclude a renal leak. They could reflect smaller average calcium losses, due perhaps to a less severe renal defect. This would explain why PTH levels are generally lower in intermittent than in persistent IH. Alternatively, the high and normal PTH forms of IH may be based upon fundamentally different mechanisms.
